scholarly journals Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations

2019 ◽  
Vol 10 ◽  
Author(s):  
Laia Carreté ◽  
Ewa Ksiezopolska ◽  
Emilia Gómez-Molero ◽  
Adela Angoulvant ◽  
Oliver Bader ◽  
...  
2017 ◽  
Vol 7 (8) ◽  
pp. 2413-2426 ◽  
Author(s):  
Luis Vale-Silva ◽  
Emmanuel Beaudoing ◽  
Van Du T. Tran ◽  
Dominique Sanglard

2018 ◽  
Vol 118 ◽  
pp. 21-31 ◽  
Author(s):  
Osney Leiva-Peláez ◽  
Guadalupe Gutiérrez-Escobedo ◽  
Eunice López-Fuentes ◽  
José Cruz-Mora ◽  
Alejandro De Las Peñas ◽  
...  

2001 ◽  
Vol 45 (4) ◽  
pp. 1174-1183 ◽  
Author(s):  
Dominique Sanglard ◽  
Francoise Ischer ◽  
Jacques Bille

ABSTRACT Candida glabrata has been often isolated from AIDS patients with oropharyngeal candidiasis treated with azole antifungal agents, especially fluconazole. We recently showed that the ATP-binding-cassette (ABC) transporter gene CgCDR1 was upregulated in C. glabrata clinical isolates resistant to azole antifungal agents (D. Sanglard, F. Ischer, D. Calabrese, P. A. Majcherczyk, and J. Bille, Antimicrob. Agents Chemother. 43:2753–2765, 1999). Deletion of CgCDR1 in C. glabrata rendered the null mutant hypersusceptible to azole derivatives and showed the importance of this gene in mediating azole resistance. We observed that wild-type C. glabrata exposed to fluconazole in a medium containing the drug at 50 μg/ml developed resistance to this agent and other azoles at a surprisingly high frequency (2 × 10−4 to 4 × 10−4). We show here that this high-frequency azole resistance (HFAR) acquired in vitro was due, at least in part, to the upregulation ofCgCDR1. The CgCDR1 deletion mutant DSY1041 could still develop HFAR but in a medium containing fluconazole at 5 μg/ml. In the HFAR strain derived from DSY1041, a distinct ABC transporter gene similar to CgCDR1, calledCgCDR2, was upregulated. This gene was slightly expressed in clinical isolates but was upregulated in strains with the HFAR phenotype. Deletion of both CgCDR1 and CgCDR2suppressed the development of HFAR in a medium containing fluconazole at 5 μg/ml, showing that both genes are important mediators of resistance to azole derivatives in C. glabrata. We also show here that the HFAR phenomenon was linked to the loss of mitochondria in C. glabrata. Mitochondrial loss could be obtained by treatment with ethidium bromide and resulted in acquisition of resistance to azole derivatives without previous exposure to these agents. Azole resistance obtained in vitro by HFAR or by agents stimulating mitochondrial loss was at least linked to the upregulation of both CgCDR1 and CgCDR2.


2005 ◽  
Vol 49 (8) ◽  
pp. 3544-3545 ◽  
Author(s):  
E. R. Oliveira ◽  
A. W. Fothergill ◽  
W. R. Kirkpatrick ◽  
B. J. Coco ◽  
T. F. Patterson ◽  
...  

ABSTRACT Combinations of caspofungin and posaconazole were evaluated by fractional inhibitory concentration index against 119 Candida glabrata isolates. Synergy was seen in 18% of all isolates and in 4% of fluconazole-resistant isolates at 48 h without evidence of antagonism. This antifungal combination may have utility against this organism.


2010 ◽  
Vol 5 (3) ◽  
pp. 318-323 ◽  
Author(s):  
Soňa Kucharíková ◽  
Patrick Dijck ◽  
Magdaléna Lisalová ◽  
Helena Bujdáková

AbstractIn the last decade, infections caused by Candida glabrata have become more serious, particularly due to its decreased susceptibility to azole derivatives and its ability to form biofilm. Here we studied the resistance profile of 42 C. glabrata clinical isolates to different azoles, amphotericin B and echinocandins. This work was also focused on the ability to form biofilm which plays a role in the development of antifungal resistance. The minimal inhibitory concentration testing to antifungal agents was performed according to the CLSI (Clinical and Laboratory Standards Institute) M27-A3 protocol. Quantification of biofilm was done by XTT reduction assay. All C. glabrata clinical isolates were resistant to itraconazole and sixteen also showed resistance to fluconazole. All isolates remained susceptible to voriconazole. Amphotericin B was efficient in a concentration range of 0.125–1 mg/L. The most effective antifungal agents were micafungin and caspofungin with the MIC100 values of ≤0.0313–0.125 mg/L. Low concentrations of these agents reduced biofilm formation as well. Our results show that resistance of different C. glabrata strains is azole specific and therefore a single azole resistance cannot be assumed to indicate general azole resistance. Echinocandins proved to have very high efficacy against clinical C. glabrata strains including those with ability to form biofilm.


2013 ◽  
Vol 175 (3-4) ◽  
pp. 207-219 ◽  
Author(s):  
Verónica Martínez-Jiménez ◽  
Candy Y. Ramírez-Zavaleta ◽  
Emmanuel Orta-Zavalza ◽  
Gabriel Díaz de León ◽  
Guadalupe Gutiérrez-Escobedo ◽  
...  

2007 ◽  
Vol 71 (3) ◽  
pp. 325-331 ◽  
Author(s):  
Mohammed Essendoubi ◽  
Dominique Toubas ◽  
Claire Lepouse ◽  
Alain Leon ◽  
Fabienne Bourgeade ◽  
...  

Phytomedicine ◽  
2015 ◽  
Vol 22 (6) ◽  
pp. 666-678 ◽  
Author(s):  
Estefanía Butassi ◽  
Laura A. Svetaz ◽  
Juan J. Ivancovich ◽  
Gabriela E. Feresin ◽  
Alejandro Tapia ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document